Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Circular No. SEBI/HO/CFD/ CFD -PoD1/P/CIR/2023/123 dated 13th July 2023 and in reference to its intimation dated 20 July, 2023, EFC (I) has informed that, the Company has received ‘No Objection Letter’ from BSE in regards to the Scheme of Arrangement between the company (‘Transferee’) and Whitehills Interior (‘Transferor’), and their respective Shareholders (‘the Scheme’). Wherein BSE have issued a ‘No Adverse Observation’ on the Scheme and approved it. The Stock Exchange Letter is enclosed. The effectiveness of the Scheme will be subject to the approval of National Company Law Tribunal and other necessary approvals as may be required.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Indegene | 505.75 |
| Syngene Internatl. | 418.85 |
| CMS Info Systems | 270.95 |
| JITF Infralogistics | 352.65 |
| Sun Pharma Adv. Res | 215.10 |
| View more.. | |
Start Research-backed Investing ...Now. Subscribe to Sapphire
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: